5-Bromo-2-methyl-2H-pyrazolo[3,4-b]pyridine, 95.0%, 10g

1-Chloro-4-(prop-2-yn-1-yloxy)benzene, 97%, 250mg

(4S,5R)-Methyl 2,2,5-trimethyl-1,3-dioxolane-4-carboxylate, 95.0%, 5g

2-Ethylcyclohexanol (cis- and trans- mixture)>97.0%(GC)25mL

tert-Butyl 3-amino-9-azabicyclo[3.3.1]nonane-9-carboxylate, 95.0%, 5g

(S)-4-methyl-N-((R)-1-(((R)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide, 98%, 10mg

Methyl 2-(5-fluoro-2-nitrophenyl)acetate, 95.0%, 5g

2-Methyl-3-(trifluoromethyl)phenylboronic acid, 95.0%, 1g

tert-Butyl 4-hydroxy-3-(hydroxymethyl)piperidine-1-carboxylate, 95.0%, 2g

(S)-2-Amino-2-(4-bromophenyl)acetic acid hydrochloride, 95.0%, 1g

N-(TERT-BUTYL)-3-METHOXY-N'-(3-METHOXY-2-METHYLBENZOYL)-2-METHYLBENZOHYDRAZIDE, 95.0%, 250mg

4-Amino-3-methyl-2-naphthoic acid, 95+%, 100mg

2-Hydroxy-4-methoxy-benzaldehyde, 98.0%, 25g